Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Current Assets (2020 - 2025)

Sight Sciences has reported Current Assets over the past 6 years, most recently at $112.7 million for Q4 2025.

  • Quarterly results put Current Assets at $112.7 million for Q4 2025, down 19.35% from a year ago — trailing twelve months through Dec 2025 was $112.7 million (down 19.35% YoY), and the annual figure for FY2025 was $112.7 million, down 19.35%.
  • Current Assets for Q4 2025 was $112.7 million at Sight Sciences, down from $113.6 million in the prior quarter.
  • Over the last five years, Current Assets for SGHT hit a ceiling of $287.8 million in Q3 2021 and a floor of $47.4 million in Q2 2021.
  • Median Current Assets over the past 5 years was $162.9 million (2023), compared with a mean of $173.7 million.
  • Peak annual rise in Current Assets hit 401.22% in 2022, while the deepest fall reached 24.31% in 2022.
  • Sight Sciences' Current Assets stood at $277.0 million in 2021, then decreased by 24.31% to $209.7 million in 2022, then fell by 22.32% to $162.9 million in 2023, then fell by 14.18% to $139.8 million in 2024, then fell by 19.35% to $112.7 million in 2025.
  • The last three reported values for Current Assets were $112.7 million (Q4 2025), $113.6 million (Q3 2025), and $119.4 million (Q2 2025) per Business Quant data.